Latest filing published 18 Sept 2024 for Alimera Sciences INC.
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Caligan Partners LP has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Standard Biotools Inc., Liquidia Corp and Alimera Sciences Inc. Between 16 November 2020 and 16 September 2024, the trades on record add up to 38 filings.
In open-market terms, that means 27 purchases worth €29.0M on one side and 2 sales worth €3.1M on the other. Purchases outweigh sales by €25.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. Since January 2024: 1 purchase and 1 sale on the market.
A typical purchase (the median) is worth €436k. 4 out of 25 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 18 September 2024 came the latest disclosure, a transaction in Alimera Sciences Inc. The clock since the last published purchase (4 September 2024) now reads 779 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations